Clinical Trial Update: A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 lot-consistency trial of a live attenuated varicella vaccine developed by Sinovac has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varicella vaccine, live attenuated (varicella vaccine, live attenuated)

Snippet

Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. | Conditions: Varicella | Phase 3 | Status: COMPLETED